Increased levels of a unique post-translationally modified βIVb-tubulin isotype in liver cancer

Biochemistry

Volumn 47, Issue 28, 2008, Pages 7572-7582

  Miller, Leah M ^a   Menthena, Anuradha ^a   Chatterjee, Champak ^b   Verdier Pinard, Pascal ^a   Novikoff, Phyllis M ^a   Horwitz, Susan Band ^a   Angeletti, Ruth Hogue ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; CELL PROLIFERATION; CHEMOTHERAPY; DRUG DELIVERY; DRUG DOSAGE; DRUG INTERACTIONS; ELECTROPHORESIS; FLOW INTERACTIONS; HEALTH; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PATHOLOGY; PHOTORESISTS; PLANTS (BOTANY); PORT TERMINALS; PRESSURE EFFECTS; PROTEINS; TISSUE;

AMERICAN CHEMICAL SOCIETY (ACS); C TERMINUS; C-TERMINAL DOMAIN (CTD); CELL SHAPES; CYANOGEN BROMIDES; CYTOSKELETON (CSK); GLUTAMIC ACID (GLU); HEPATOCELLULAR CARCINOMA (HCC); HUMAN LIVER; HYDROPHOBIC RESIDUES; IN CONTROL; IN-CELL; ISOELECTRIC FOCUSSING; ISOTYPES; LIVER CANCERS; LIVER TISSUES; LUNG TISSUES; MICROTUBULE (MT); MICROTUBULE STABILITY; MICROTUBULES (MT); MOLECULAR LEVELS; POSTTRANSLATIONAL MODIFICATION (PTM); PROTEIN POLYMERS; RAT LIVERS; STRUCTURAL REORGANIZATION; TUMOR TISSUES; VESICLE TRANSPORT;

LIVER;

ALPHA TUBULIN; BETA TUBULIN; BETAIVB TUBULIN; CYANOGEN BROMIDE; GLUTAMIC ACID; TUBULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STAGING; CARBOXY TERMINAL SEQUENCE; CELL DIVISION; CELL MOTILITY; CELL SHAPE; CELL TRANSPORT; CONTROLLED STUDY; CYTOSKELETON; DRUG SENSITIVITY; ISOELECTRIC FOCUSING; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LUNG METASTASIS; MALE; MASS SPECTROMETRY; MICROTUBULE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEIN PURIFICATION; RAT;

AMINO ACID SEQUENCE; ANIMALS; HEPATOCYTES; ISOELECTRIC FOCUSING; LIVER NEOPLASMS; MALE; MOLECULAR SEQUENCE DATA; PACLITAXEL; PEPTIDE FRAGMENTS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, INBRED F344; TUBULIN;

RATTUS;

EID: 47249083926     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi8005225     Document Type: Article

References (50)

1. Desai, A., and Mitchison, T. J. ( 1997) Microtubule polymerization dynamics. Annu. Rev. Cell Dev. Biol. 13, 83-117.
2. Nogales, E. (2000) Structural insights into microtubule function. Annu. Rev. Biochem. 69, 277-302.
3. Luduena, R. F. (1998) Multiple forms of tubulin: Different gene products and covalent modifications. Int. Rev. Cytol. 178, 207-275.
4. Sullivan, K. F., and Cleveland, D. W. (1986) Identification of conserved isotype-defining variable region sequences for four vertebrate β-tubulin polypeptide classes. Proc. Natl. Acad. Sci. U.S.A. 83, 4327-4331.
5. Westermann, S., and Weber, K. (2003) Post-translational modifications regulate microtubule function. Nat. Rev. Mol. Cell Biol. 4, 938-947.
6. Sullivan, K. F. (1988) Structure and utilization of tubulin isotypes. Annu. Rev. Cell Biol. 4, 687-716.
7. Luduena, R. F. (1993) Are tubulin isotypes functionally significant. Mol. Biol. Cell 4, 445-457.
8. Panda, D., Miller, H. P., Banerjee, A., Luduena, R. F., and Wilson, L. (1994) Microtubule dynamics in vitro are regulated by the tubulin isotype composition. Proc. Natl. Acad. Sci. U.S.A. 91, 11358-11362.
9. Orr, G. A., Verdier-Pinard, P., McDaid, H., and Horwitz, S. B. (2003) Mechanisms of Taxol resistance related to microtubules. Oncogene 22, 7280-7295.
10. Verhey, K. J., and Gaertig, J. (2007) The tubulin code. Cell Cycle 6, 2152-2160.
11. Gan, P. P., Pasquier, E., and Kavallaris, M. (2007) Class III β-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer. Cancer Res. 67, 9356-9363.
12. Kavallaris, M., Kuo, D. Y., Burkhart, C. A., Regl, D. L., Norris, M. D., Haber, M., and Horwitz, S. B. (1997) Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes. J. Clin. Invest. 100, 1282-1293.
13. Katsetos, C. D., Herman, M. M., and Mork, S. J. (2003) Class III β-tubulin in human development and cancer. Cell Motil. Cytoskeleton 55, 77-96.
14. Lee, K. M., Cao, D., Itami, A., Pour, P. M., Hruban, R. H., Maitra, A., and Ouellette, M. M. (2007) Class III β-tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia. Histopathology 51, 539-546.
15. Seve, P., Isaac, S., Tredan, O., Souquet, P. J., Pacheco, Y., Perol, M., Lafanechere, L., Penet, A., Peiller, E. L., and Dumontet, C. (2005) Expression of class III β-tubulin is predictive of patient outcome in patients with non-small cell lung cancer receiving vinorelbine-based chemotherapy. Clin. Cancer Res. 11, 5481-5486.
16. Oda, E., Nakamura, Y., Yamamoto, M., and Kojiro, M. (2005) Immunohistochemical distribution of tubulin βII in human normal and neoplastic tissues. Kurume Med. J. 52, 117-125.
17. Soucek, K., Kamaid, A., Phung, A. D., Kubala, L., Bulinski, J. C., Harper, R. W., and Eiserich, J. P. (2006) Normal and prostate cancer cells display distinct molecular profiles of α-tubulin posttranslational modifications. Prostate 66, 954-965.
18. Verdier-Pinard, P., Wang, F., Burd, B., Angeletti, R. H., Horwitz, S. B., and Orr, G. A. (2003) Direct analysis of tubulin expression in cancer cell lines by electrospray ionization mass spectrometry. Biochemistry 42, 12019-12027.
19. Alexander, J. E., Hunt, D. F., Lee, M. K., Shabanowitz, J., Michel, H., Berlin, S. C., MacDonald, T. L., Sundberg, R. J., Rebhun, L. I., and Frankfurter, A. (1991) Characterization of posttranslational modifications in neuron-specific class III β-tubulin by mass spectrometry. Proc. Natl. Acad. Sci. U.S.A. 88, 4685-4689.
20. Vinh, J., Langridge, J. I., Bre, M. H., Levilliers, N., Redeker, V., Loyaux, D., and Rossier, J. (1999) Structural characterization by tandem mass spectrometry of the posttranslational polyglycylation of tubulin. Biochemistry 38, 3133-3139.
21. Verdier-Pinard, P., Wang, F., Martello, L., Burd, B., Orr, G. A., and Horwitz, S. B. (2003) Analysis of tubulin isotypes and mutations from taxol-resistant cells by combined isoelectrofocusing and mass spectrometry. Biochemistry 42, 5349-5357.
22. Rao, S., Aberg, F., Nieves, E., Horwitz, S. B., and Orr, G. A. (2001) Identification by mass spectrometry of a new α-tubulin isotype expressed in human breast and lung carcinoma cell lines. Biochemistry 40, 2096-2103.
23. Verdier-Pinard, P., Shahabi, S., Wang, F., Burd, B., Xiao, H., Goldberg, G. L., Orr, G. A., and Horwitz, S. B. (2005) Detection of human βV-tubulin expression in epithelial cancer cell lines by tubulin proteomics. Biochemistry 44, 15858-15870.
24. Solt, D. B., Medline, A., and Farber, E. (1977) Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis. Am. J. Pathol. 88, 595-618.
25. Garcia, M., Jemal, A., Ward, E. M., Center, M. M., Hao, Y., Siegel, R. I., and Thun, M. J. (2007) Global Cancer Facts & Figures 2007, American Cancer Society, New York.
26. Farazi, P. A., and DePinho, R. A. (2006) Hepatocellular carcinoma pathogenesis: From genes to environment. Nat. Rev. Cancer 6, 674-687.
27. Luo, Q., Siconolfi-Baez, L., Annamaneni, P., Bielawski, M. T., Novikoff, P. M., and Angeletti, R. H. (2007) Altered protein expression at early-stage rat hepatic neoplasia. Am. J. Physiol. 292, G1272-G1282.
28. Lapatsanis, L., Milias, G., Froussios, L., and Kolovos, M. (1983) Synthesis of N-(2,2,2-trichloroethoxycarbonyl) L-amino acids and N-(9-fluorenylmethoxycarbonyl) L-amino acids involving succinimidoxy anion as a leaving group in amino acid protection. Synthesis 8, 673-673.
29. Kempe, T., Chow, F., Peterson, S. M., Baker, P., Hays, W., Opperman, G., L'Italien, J. J., Long, G., and Paulson, B. (1986) Production and Characterization of Growth Hormone Releasing Factor Analogs Through Recombinant DNA and Chemical Techniques. Nat. Biotechnol. 4, 565-568.
30. Perkins, D. N., Pappin, D. J., Creasy, D. M., and Cottrell, J. S. (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20, 3551-3567.
31. Boguski, M. S., Lowe, T. M., and Tolstoshev, C. M. (1993) dbEST: Database for "expressed sequence tags". Nat. Genet. 4, 332-333.
32. Farber, E., Cameron, R. G., Laishes, B., Lin, J.-C., Medline, A., Ogawa, K. , and Solt, D. B. (1979) in Carcinogens: Identification and Mechanisms of Action (Griffin, A. C., and S., R. S., Eds.) pp 319-335, Raven Press, New York.
33. van Dijk, J., Miro, J., Strub, J. M., Lacroix, B., van Dorsselaer, A., Edde, B., and Janke, C. (2008) Polyglutamylation is a posttranslational modification with a broad range of substrates. J. Biol. Chem. 283, 3915-3922.
34. Regnard, C., Desbruyeres, E., Huet, J. C., Beauvallet, C., Pernollet, J. C., and Edde, B. (2000) Polyglutamylation of nucleosome assembly proteins. J. Biol. Chem. 275, 15969-15976.
35. Rosenbaum, J. (2000) Cytoskeleton: Functions for tubulin modifications at last. Curr. Biol. 10, R801-R803.
36. Bonnet, C., Boucher, D., Lazereg, S., Pedrotti, B., Islam, K., Denoulet, P., and Larcher, J. C. (2001) Differential binding regulation of microtubule-associated proteins MAP1A, MAP1B, and MAP2 by tubulin polyglutamylation. J. Biol. Chem. 276, 12839-12848.
37. Larcher, J. C., Boucher, D., Lazereg, S., Gros, F., and Denoulet, P. (1996) Interaction of kinesin motor domains with α- and β-tubulin subunits at a τ-independent binding site. Regulation by polyglutamylation. J. Biol. Chem. 271, 22117-22124.
38. Raybin, D., and Flavin, M. (1977) Enzyme which specifically adds tyrosine to the α chain of tubulin. Biochemistry 16, 2189-2194.
39. MacRae, T. H. (1997) Tubulin post-translational modifications: Enzymes and their mechanisms of action. Eur. J. Biochem. 244, 265-278.
40. Ersfeld, K., Wehland, J., Plessmann, U., Dodemont, H., Gerke, V., and Weber, K. (1993) Characterization of the tubulin-tyrosine ligase. J. Cell Biol. 120, 725-732.
41. Paturle-Lafanechere, L., Edde, B., Denoulet, P., Van Dorsselaer, A., Mazarguil, H., Le Caer, J. P., Wehland, J., and Job, D. (1991) Characterization of a major brain tubulin variant which cannot be tyrosinated. Biochemistry 30, 10523-10528.
42. Paturle-Lafanechere, L., Manier, M., Trigault, N., Pirollet, F., Mazarguil, H., and Job, D. (1994) Accumulation of δ2-tubulin, a major tubulin variant that cannot be tyrosinated, in neuronal tissues and in stable microtubule assemblies. J. Cell Sci. 107, 1529-1543.
43. Gundersen, G., Khawaja, S., and Bulinski, J. (1987) Postpolymerization detyrosination of α-tubulin: A mechanism for subcellular differentiation of microtubules. J. Cell Biol. 105, 251-264.
44. Mialhe, A., Lafanechere, L., Treilleux, I., Peloux, N., Dumontet, C., Bremond, A., Panh, M.-H., Payan, R., Wehland, J., Margolis, R.-L., and Job, D. (2001) Tubulin Detyrosination Is a Frequent Occurrence in Breast Cancers of Poor Prognosis. Cancer Res. 61, 5024-5027.
45. Lafanechere, L., Courtay-Cahen, C., Kawakami, T., Jacrot, M., Rudiger, M., Wehland, J., Job, D., and Margolis, R. L. (1998) Suppression of tubulin tyrosine ligase during tumor growth. J. Cell Sci. 111 (2), 171-181.
46. Rawlings, N. D., Morton, F. R., Kok, C. Y., Kong, J., and Barrett, A. J. (2008) MEROPS: The peptidase database. Nucleic Acids Res. 36, D320-D325.
47. Kalinina, E., Biswas, R., Berezniuk, I., Hermoso, A., Aviles, F. X., and Fricker, L. D. (2007) A novel subfamily of mouse cytosolic carboxypeptidases. FASEB J. 21, 836-850.
48. Rodriguez de la Vega, M., Sevilla, R. G., Hermoso, A., Lorenzo, J., Tanco, S., Diez, A., Fricker, L. D., Bautista, J. M., and Aviles, F. X. (2007) Nna1-like proteins are active metallocarboxypeptidases of a new and diverse M14 subfamily. FASEB J. 21, 851-865.
49. Koblinski, J. E., Ahram, M., and Sloane, B. F. (2000) Unraveling the role of proteases in cancer. Clin. Chim. Acta 291, 113-135.
50. Khodiyar, V. K., Maltais, L. J., Sneddon, K. M. B., Smith, J. R., Shimoyama, M., Cabral, F., Dumontet, C., Dutcher, S. K., Harvey, R. J., Lafanechere, L., Murray, J. M., Nogales, E., Piquemal, D., Stanchi, F., Povey, S., and Lovering, R. C. (2007) A revised nomenclature for the human and rodent α-tubulin gene family. Genomics 90, 285-289.